Cradle, which operated in Zurich and Delft, raised USD 24 million in Series A funding led by Index Ventures, with participation from Kindred Capital and angel investors including Chris Gibson and Tom Glocer. The round brought its total financing to USD 33 million. Cradle planned to expand its machine-learning and biotechnology team, develop its software and strengthen sales capabilities.
The company used generative AI to help scientists design proteins with selected properties, including stability, activity and binding affinity. At the announcement, its 20-person team was working with nine industry partners, including Janssen Research & Development, Novozymes and Twist Bioscience, across more than a dozen research projects. Its web-based platform was designed for experimental scientists without requiring machine-learning expertise.
